Amyloid precursor protein in peripheral granulocytes as a potential biomarker for alzheimer’s disease

Bangladesh Journal of Pharmacology

Volumn 11, Issue , 2016, Pages S92-S97

  Wang, Xiaonan ^a   Li, Xihai ^a   Yang, Jie ^a   Yu, Ming ^b   Wu, Jinmei ^a  

^a JIANGSU UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b AFFILIATED HOSPITAL OF JIANGSU UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PRECURSOR PROTEIN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; EARLY DIAGNOSIS; FEMALE; FLOW CYTOMETRY; GRANULOCYTE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LEUKOCYTE; LYMPHOCYTE; MALE; MONOCYTE; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; VERY ELDERLY;

EID: 84960089979     PISSN: 1991007X     EISSN: 19910088     Source Type: Journal    
DOI: 10.3329/bjp.v11iS1.26412     Document Type: Article

References (26)

1. Avila J, Perez M, Lucas JJ, Gomez-Ramos A, Santa Maria I, Moreno F, Smith M, Perry G, Hernandez F. Assembly in vitro of tau protein and its implications in Alzheimer's disease. Curr Alzheimer Res. 2004; 1: 97-101.
2. Blennow K. CSF biomarkers for Alzheimer's disease: Use in early diagnosis and evaluation of drug treatment. Expert Rev Mol Diagn. 2005; 5: 661-672.
3. Blennow K, Hampel H, Weiner M, Zetterberg H. Cerebro-spinal fluid and plasma biomarkers in Alzheimer disease. Nat Rev Neurol. 2010; 6: 131-144.
4. Borroni B, Colciaghi F, Corsini P, Akkawi N, Rozzini L, Del Zotto E, Talarico G, Cattabeni F, Lenzi GL, Di Luca M, Padovani A. Early stages of probable Alzheimer disease are associated with changes in platelet amyloid precursor protein forms. Neurol Sci. 2002; 23: 207-210.
5. Davydova TV, Fomina VG, Voskresenskaya NI, Doronina OA. Phagocytic activity and state of bactericidal systems in poly-morphonuclear leukocytes from patients with Alzheimer's disease. Bull Exp Biol Med. 2003; 136: 355-357.
6. Di Luca M, Colciaghi F, Pastorino L, Borroni B, Padovani A, Cattabeni F. Platelets as a peripheral district where to study pathogenetic mechanisms of alzheimer disease: The case of amyloid precursor protein. Eur J Pharmacol. 2000; 405: 277-283.
7. Dulubova I, Ho A, Huryeva I, Sudhof TC, Rizo J. Three-dimensional structure of an independently folded extracellular domain of human amyloid-beta precursor protein. Biochemistry 2004; 43: 9583-9588.
8. Evin G, Li QX. Platelets and Alzheimer's disease: Potential of APP as a biomarker. World J Psychiatr. 2012; 2: 102-113.
9. Fiala M, Lin J, Ringman J, Kermani-Arab V, Tsao G, Patel A, Lossinsky AS, Graves MC, Gustavson A, Sayre J, Sofroni E, Suarez T, Chiappelli F, Bernard G. Ineffective phagocytosis of amyloid-beta by macrophages of Alzheimer's disease patients. J Alzheimers Dis. 2005; 7: 221-232.
10. Gustaw-Rothenberg KA, Siedlak SL, Bonda DJ, Lerner A, Tabaton M, Perry G, Smith MA. Dissociated amyloid-beta antibody levels as a serum biomarker for the progression of Alzheimer's disease: A population-based study. Exp Gerontol. 2010; 45: 47-52.
11. Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics. Science 2002; 297: 353-356.
12. Hou Y, Chen H, He Q, Jiang W, Luo T, Duan J, Mu N, He Y, Wang H. Changes in methylation patterns of multiple genes from peripheral blood leucocytes of Alzheimer's disease patients. Acta Neuropsychiatr. 2013; 25: 66-76.
13. Jaremo P, Milovanovic M, Buller C, Nilsson S, Winblad B. Alzheimer's disease and granulocyte density diversity. Eur J Clin Invest. 2013; 43: 545-548.
14. Jiang S, Zhang M, Ren D, Tang G, Lin S, Qian Y, Zhang Y, Jiang K, Li F, Wang D. Enhanced production of amyloid precursor protein mRNA by peripheral mononuclear blood cell in Alzheimer's disease. Am J Med Genet B Neuro- psychiatr Genet. 2003; 118b: 99-102.
15. Kawahara M. Disruption of calcium homeostasis in the patho-genesis of Alzheimer's disease and other conformational diseases. Curr Alzheimer Res. 2004; 1: 87-95.
16. Li QX, Fuller SJ, Beyreuther K, Masters CL. The amyloid precursor protein of Alzheimer disease in human brain and blood. J Leukoc Biol. 1999; 66: 567-574.
17. Li QX, Whyte S, Tanner JE, Evin G, Beyreuther K, Masters CL. Secretion of Alzheimer's disease Abeta amyloid peptide by activated human platelets. Lab Invest. 1998; 78: 461-469.
18. Magaki S, Yellon SM, Mueller C, Kirsch WM. Immunopheno-types in the circulation of patients with mild cognitive impairment. J Psychiatr Res. 2008; 42: 240-246.
19. Mangialasche F, Westman E, Kivipelto M, Muehlboeck JS, Cecchetti R, Baglioni M, Tarducci R, Gobbi G, Floridi P, Soininen H, Kloszewska I, Tsolaki M, Vellas B, Spenger C, Lovestone S, Wahlund LO, Simmons A, Mecocci P. Classification and prediction of clinical diagnosis of Alzheimer's disease based on MRI and plasma measures of alpha-/ gamma-tocotrienols and gamma-tocopherol. J Intern Med. 2013; 273: 602-621.
20. Marksteiner J, Hinterhuber H, Humpel C. Cerebrospinal fluid biomarkers for diagnosis of Alzheimer's disease: Beta-amyloid (1-42), tau, phospho-tau-181 and total protein. Drugs Today (Barc). 2007; 43: 423-431.
21. Mukaetova-Ladinska EB, Abdel-All Z, Dodds S, Andrade J, Alves da Silva J, Kalaria RN, O'Brien JT. Platelet immunoglo-bulin and amyloid precursor protein as potential peripheral biomarkers for Alzheimer's disease: Findings from a pilot study. Age Ageing. 2012; 41: 408-412.
22. Padovani A, Borroni B, Colciaghi F, Pettenati C, Cottini E, Agosti C, Lenzi GL, Caltagirone C, Trabucchi M, Cattabeni F, Di Luca M. Abnormalities in the pattern of platelet amyloid precursor protein forms in patients with mild cognitive impairment and Alzheimer disease. Arch Neurol. 2002; 59: 71-75.
23. Ratnavalli E, Brayne C, Dawson K, Hodges JR. The prevalence of frontotemporal dementia. Neurology 2002; 58: 1615-21.
24. Shad KF, Aghazadeh Y, Ahmad S, Kress B. Peripheral markers of Alzheimer's disease: Surveillance of white blood cells. Synapse 2013; 67: 541-543.
25. Tabaton M, Piccini A. Role of water-soluble amyloid-beta in the pathogenesis of Alzheimer's disease. Int J Exp Pathol. 2005; 86: 139-145.
26. Tortosa A, Lopez E, Ferrer I. Bcl-2 and Bax protein expression in Alzheimer's disease. Acta Neuropathol. 1998; 95: 407-412.